Eleven Biotherapeutics Receives $13,525,262 New Funding Round

  • Feed Type
  • Date
    9/29/2016
  • Company Name
    Eleven Biotherapeutics
  • Mailing Address
    215 First Street Cambridge, MA 02142 USA
  • Company Description
    Eleven Biotherapeutics is focused on developing innovative protein-based therapeutics to improve human health and treat diseases.
  • Website
    http://www.elevenbio.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $13,525,262
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    Proceeds purposes were not disclosed. 6 investors participated in the offering. The amount may include options, warrants or other securities. Contact technology company for investment details, if applicable. Not an offer or solicitation for the sale of securities or debt. SEC regulatory filing.
  • M&A Terms
  • Venture Investor
    Undisclosed

Trending on Xconomy